Status:
RECRUITING
Multi Modal Cardiac Imaging Prior Transcatheter Aortic Valve Implantation
Lead Sponsor:
Klinik für Kardiologie, Pneumologie und Angiologie
Conditions:
Aortic Valve Stenosis
Eligibility:
All Genders
18+ years
Brief Summary
Transcatheter aortic valve implantation (TAVI) is an emerging alternative therapy for aortic stenosis for patients ineligible for open heart surgery or at high risk for perioperative complications. Pr...
Detailed Description
Transcatheter aortic valve implantation (TAVI) is an emerging alternative therapy for aortic stenosis for patients ineligible for open heart surgery or at high risk for perioperative complications. Pr...
Eligibility Criteria
Inclusion
- aortic valve stenosis
- screened for TAVI
- written informed consent
Exclusion
- unconsciousness, not able to consent
Key Trial Info
Start Date :
January 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2030
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT01805739
Start Date
January 1 2013
End Date
December 1 2030
Last Update
October 30 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Division of Cardiology, Pulmonary Diseases, Vascular Medicine, University Hospital Duesseldorf
Düsseldorf, North Rhine-Westphalia, Germany, 40225